Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control-Reference-Cited by-同舟云学术

Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control

Published:2021-01 Issue: Volume:154 Page:207-213
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Levin-Epstein Rebecca G.^ORCID,Jiang Naomi Y.,Wang Xiaoyan,Upadhyaya Shrinivasa K.,Collins Sean P.,Suy Simeng,Aghdam Nima,Mantz Constantine^ORCID,Katz Alan J.^ORCID,Miszczyk Leszek,Napieralska Aleksandra,Namysl-Kaletka Agnieszka,Prionas Nicholas,Bagshaw Hilary,Buyyounouski Mark K.,Cao Minsong^ORCID,Agazaryan Nzhde,Dang Audrey,Yuan Ye,Kupelian Patrick A.,Zaorsky Nicholas G.^ORCID,Spratt Daniel E.,Mohamad Osama^ORCID,Feng Felix Y.,Mahal Brandon A.,Boutros Paul C.^ORCID,Kishan Arun U.,Juarez Jesus^ORCID,Shabsovich David,Jiang Tommy,Kahlon Sartajdeep,Patel Ankur,Patel Jay,Nickols Nicholas G.,Steinberg Michael L.,Fuller Donald B.^ORCID,Kishan Amar U.

Funder

American Society for Radiation Oncology

Prostate Cancer Foundation

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference40 articles.

1. National Comprehensive Cancer Network. NCCN Guidelines: Prostate Cancer version 2.2020. https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed June 2, 2020.

2. Stereotactic body radiation therapy for localized prostate cancer: A systematic review and meta-analysis of over 6,000 patients treated on prospective studies;Jackson;Int J Radiat Oncol Biol Phys,2019

3. Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer;Parthan;Front Oncol,2012

4. How low is the alpha/beta ratio for prostate cancer?;Wang;Int J Radiat Oncol Biol Phys,2003

5. Is α/β for prostate tumors really low?;Fowler;Int J Radiat Oncol Biol Phys,2001

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Intermediate- to High-Risk Prostate Cancer: Primary Outcomes of the SPARC Phase 2 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-09

2. Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Men With Hip Prostheses: A Cautionary Note;Cureus;2024-05-31

3. Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer;Frontiers in Oncology;2024-03-22

4. Stereotactic body radiotherapy for distant metastases to the head and neck;Supportive Care in Cancer;2024-03-15

5. Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial;Frontiers in Oncology;2023-11-07